An analysis of electronic health records of nearly 580,000 fully vaccinated people in the United States found that the risk
Study finds increased risk for SARS-CoV-2 breakthrough infections in people with substance use disorders
Home ยป
Study shows impaired SARS-CoV-2 mRNA vaccine antibody response in individuals with chronic conditions
COVID-19 vaccines have led to drastic decreases in the number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases and
Study compares Pfizer and Moderna mRNA vaccine-elicited response to SARS-CoV-2 variants
The ongoing coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious
New testing protocol for SARS-CoV-2 can process thousands of samples within 48 hours
Researchers at the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in
Genetically engineered intestinal organoids reveal potential treatment targets against SARS-CoV-2
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2
Plant-based vaccine against SARS-CoV-2 shows promise
Researchers at Canadian biotechnology company Medicago report that Phase 1 trials of a plant-based vaccine for SARS-CoV-2 are underway and
Triple mutation in SARS-CoV-2 seen in second wave of COVID-19 in India
Researchers sequenced the viral genome from samples in the state of Maharashtra and found a unique combination of three mutations
Neonates exposed to SARS-CoV-2 can sustain adverse health outcomes
The incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from mothers to newborns appears low and may be
Rapid mRNA vaccination effectively controls SARS-CoV-2 transmission in long-term care facilities
Vaccine rollouts all over the world are aimed at cutting short the coronavirus disease 2019 (COVID-19) pandemic by inducing antibody-mediated
Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting